Type: Prevalence/cross-sectional
Study Status: Completed
Enrollment Status: Closed
Countries: Kenya; Rwanda
Partners: Kenya AIDS Vaccine Initiative-Kangemi (KAVI-Kangemi), Nairobi, Kenya; Projet San Francisco (PSF-Kigali)-Kigali, Rwanda.

Study Summary:
To characterize immune responses to HIV vaccine encoded proteins in HIV infected individuals and assess cryopreservation of Peripheral Blood Mononuclear cells in preparation for preventive vaccine studies.